NA Vaccine Institute

WHO WE ARE

Company motto

Potentiated vaccine for
global immunization

Vision statement

Innovative technology for novel vaccine

Cold chain free nasal vaccine

Peptide vaccine without pathogen

Cancer therapeutic vaccine for melanoma and HPV

A nasal stroke therapeutic drug

Business area/NAVI

T-cell Therapy, IRI Pharma sipn off, Animal vaccine, human vaccine, cancer vaccine

Members of NAVI

	Dongho Kim, Ph.D. CEO Ph.D. University of Texas at Austin Postdoc. in Beckman Research Institute of City of Hope Staff Scientist/Director of RNAi core of Beckman Research Institute of COH CEO and Founder of Cellonex, Genolution, IRI Pharma, NA Vaccine Institute Adjunct Professor, POSTECH
	Myung-soo Kang, Ph.D. COO Seoul National University Instructor at Harvard Medical School Professor at Samsung Medical Center Director at Intron Biotechnology
	John Rossi, Ph.D. Board director of scientific advisory Chair and Professor, Department of Molecular and Cellular Biology, Beckman Research Institute of the City of Hope. A World Leader in RNAi and in clinical research with nucleic acids. Co-founder of Dicerna Pharmaceuticals, Calando Pharmaceuticals, Inc.
	Hwanmook Kim, Ph.D. Scientific Advisor Seoul National university KAIST Professor, Gachn University
	Won Jong Kim, Ph.D. Scientific Advisor Ph.D. Tokyo Institute of Technology Postdoc. in University of Utah Mueunjae Chaired Professor, POSTECH
	Taerim Yun, CFO Sungkyunkwan University, MBA SK Telecom Team Leader , SK Planet Project Leader Specialist in Finance, M&A, Venture Fund Investment, Business Portfolio Management